MedTrace Logo

Continuous Monitoring of Patients With Chronic Obstructive Pulmonary Disease

NCT01741935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2013-10-31

No results posted yet for this study

Summary

An open, single group, single center Study to confirm CTC-Actiwise™ as a means to record and monitor the progression of a patient's COPD.

Chronic Obstructive Pulmonary Disease (COPD) affects growing patient groups. Current knowledge about the disease limits the investigators ability to cure or interfere with the progression of the disease. COPD is often characterized by exacerbating infections requiring emergency care.

The project aims to examine whether disease progression of COPD can be better controlled by continuously monitoring the patient's physical activity, along with the assessment of pulmonary symptoms and lung function. A key question is: can investigators find indicators that provides support for early intervention before severe symptoms arise.

The patient carries a smartphone that records physical activity real-time, daily lung function measures, lung disease related symptoms, and use of medication.

The experimental phase, the first part of the project, covers 25 COPD patients followed up to 12 weeks where the primary objective is to examine and verify both new investigational methodology and technology.

Conditions

Sponsors & Collaborators

  • Boehringer Ingelheim

    collaborator INDUSTRY

  • Region Skane

    collaborator OTHER

  • Lund University

    collaborator OTHER

  • CareTelCom AB

    lead INDUSTRY

Principal Investigators

  • Leif Bjermer, Professor · Lund University

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01741935 on ClinicalTrials.gov